Clinical Trial Update: Study of 5-FU, Oxaliplatin, & Lapatinib Combined With Radiation Therapy to Treat HER2 Positive Esophagogastric Cancer [Phase 2]

View source ↗

Summary

This is a Phase 2 trial evaluating the combination of 5-FU, oxaliplatin, and lapatinib with radiation therapy for HER2-positive esophagogastric cancer. The stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer
• Gastric Cancer

Drugs mentioned

• 5-FU (5-fluorouracil)
• Lapatinib (Lapatinib)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: SCRI Development Innovations, LLC | Conditions: HER2 Positive Esophagogastric Cancer | Phase 2 | Status: TERMINATED | Results posted: 2016-04-27